Newbridge Financial Services Group »

Seelos Therapeutics Ord shares owned by Newbridge Financial Services Group

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Newbridge Financial Services Group from 13F filings

Historical chart of Newbridge Financial Services Group investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Newbridge Financial Services Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Newbridge Financial Services Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $118 199 0.59
2023-12-31 $277 199 1.39

More positions owned by Newbridge Financial Services Group

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Vaneck Etf Trust Semiconductr Etf (SMH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Madrigal Pharmaceuticals (MDGL)
Crowdstrike Hldgs Cl A (CRWD)
Global X Fds Nasdaq 100 Cover (QYLD)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Palantir Technologies Cl A (PLTR)

View all positions for Newbridge Financial Services Group

Top funds holding Seelos Therapeutics Ord

Wealth Effects
AdvisorShares Investments
Jeffrey L. Gendell
Balyasny Asset Management
Vanguard Group
Modera Wealth Management
Morgan Stanley
Geode Capital Management
BlackRock
Strategic Family Wealth Counselors
Jane Street
XTX Topco
Two Sigma Investments
CRA Financial Services
Tower Research Capital

View all funds holding Seelos Therapeutics Ord